Prostate Cancer Mortality Rate Explained | Answering YouTube Comments #48 | Mark Scholz, MD | PCRI

Alex asks Dr. Scholz patients' questions from our YouTube comments. First, on how to reconcile the fact that the prognosis for prostate cancer patients is generally excellent with the fact that it is a leading cause of death in men. Then, why patients with metastases at initial diagnosis should be interested in adding chemotherapy to 1st and 2nd-generation hormone therapy when the survival benefit is around 2.5 years. Mark Scholz, MD is a medical oncologist specializing exclusively in the treatment of prostate cancer.

0:05 I have seen some of your videos and they have an optimistic take on prostate cancer patients' outlook, but I also see that it is one of the leading causes of death in men. How are those two facts reconciled?

1:53 Is a 2.5-year benefit from adding chemotherapy to hormone therapy and second-generation anti-androgens anything to get excited about? I'd be more excited if it was 10-15 years.

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Видео Prostate Cancer Mortality Rate Explained | Answering YouTube Comments #48 | Mark Scholz, MD | PCRI канала Prostate Cancer Research Institute